mRNA N1-2’O-methylation by CMTR1 affects NVL2 mRNA splicing

Abstract

ABSTRACTCap0-mRNA is characterized by a 5’-5’triphosphate-linked N7-methylated guanosine(m7G). In higher eukaryotes, the methyltransferase CMTR1 additionally methylates the 2’O-position of the penultimate mRNA nucleotide(N1) ribose (cap1-mRNA). While the m7G cap is essential for mRNA export and translation initiation by the eIF4F complex, the N1-2’O-methylation prevents recognition of cap1-mRNA by the antiviral RNA receptors RIG-I and IFIT1, but a function beyond immunotolerance remained elusive. Here, we generatedCMTR1-knockout(CMTR1-/-) cells and found that type-I-interferon(IFN-I) treatment resulted in IFIT1-mediated reduction of cell viability and broad mRNA translation. Consequently, stimulation of the antiviral receptor RIG-I inCMTR1-/-cells revealed an IFIT1 dependent dramatic reduction of IFN-I and chemokine protein induction, demonstrating the importance of N1-2’O-methylation for antiviral responses.Additionally, IFN-I- and IFIT1-independent effects were observed:CMTR1-/-cells were smaller, divided slower, and exhibited a reduced transcription of mRNAs coding ribosomal proteins (RP), 5’TOP-RNA and snoRNA host genes(SNHG). Additionally, proteome and transcriptome analysis revealed that expression of NVL2, an essential factor in ribosome biogenesis, is strongly suppressed by an alternative-splicing event ofNVL2 mRNAin CMTR1-/-cells. This reduction could only be rescued by catalytically active CMTR1. Altogether, besides antiviral immunity N1-2’O-methylation by CMTR1 has broad effects on cellular physiology and controls splicing of NVL2.